Sana Biotechnology, Inc. Announces 2024 Annual Meeting of Stockholders on June 6

TL;DR

<b>Sana Biotechnology, Inc. will hold its 2024 Annual Meeting of Stockholders virtually on June 6, 2024, requiring advance registration.</b>

AI Summary

Sana Biotechnology, Inc. (SANA) filed a Proxy Statement (DEF 14A) with the SEC on April 26, 2024. The 2024 Annual Meeting of Stockholders for Sana Biotechnology, Inc. will be held virtually on June 6, 2024, at 9:00 a.m. Pacific Time. Stockholders must register by 2:00 p.m. Pacific Time on June 5, 2024, at www.proxydocs.com/SANA to participate. Registration requires a control number from the Notice of Internet Availability of Proxy Materials or proxy card. Further instructions, including a unique access link, will be emailed after registration. The meeting will be conducted via live audio webcast, with no physical attendance option.

Why It Matters

For investors and stakeholders tracking Sana Biotechnology, Inc., this filing contains several important signals. This filing is a definitive proxy statement (DEF 14A) detailing the upcoming annual meeting, indicating a formal communication to shareholders regarding corporate governance and voting. The shift to a virtual-only meeting format is a common practice for accessibility and cost-efficiency, but requires specific registration steps for shareholder participation.

Risk Assessment

Risk Level: low — Sana Biotechnology, Inc. shows low risk based on this filing. The filing is a routine proxy statement for an annual meeting and does not contain new financial or operational information that would indicate significant risk.

Analyst Insight

Stockholders should review the proxy materials and register by the June 5 deadline to ensure they can participate in the virtual annual meeting and exercise their voting rights.

Key Numbers

• June 6, 2024 — Annual Meeting Date (2024 Annual Meeting of Stockholders)
• June 5, 2024 — Registration Deadline (To be admitted to and participate in the Annual Meeting)
• 2:00 p.m. Pacific Time — Registration Deadline Time (Prior to the Annual Meeting)
• 9:00 a.m. Pacific Time — Meeting Start Time (Annual Meeting)

Key Players & Entities

• Sana Biotechnology, Inc. (company) — Registrant
• June 6, 2024 (date) — Date of Annual Meeting
• June 5, 2024 (date) — Registration Deadline
• 2:00 p.m. Pacific Time (time) — Registration Deadline
• 9:00 a.m. Pacific Time (time) — Start time of Annual Meeting
• www.proxydocs.com/SANA (url) — Registration Website

FAQ

Industry Context

Sana Biotechnology operates in the biotechnology sector, focusing on developing cell and gene therapies.

Regulatory Implications

This filing is a proxy statement (DEF 14A) under the Securities Exchange Act of 1934, governing the solicitation of proxies from shareholders for company meetings.

What Investors Should Do

1. Review the proxy statement for details on proposals to be voted on at the annual meeting.
2. Register for the virtual meeting at www.proxydocs.com/SANA by June 5, 2024, 2:00 p.m. Pacific Time.
3. Ensure you have your control number ready for the registration process.

Key Dates

• 2024-06-06: 2024 Annual Meeting of Stockholders — Primary event for shareholder voting and company updates.
• 2024-06-05: Registration Deadline for Virtual Meeting — Last day for shareholders to register to attend the virtual meeting.

Year-Over-Year Comparison

This is a DEF 14A filing for the 2024 Annual Meeting, distinct from previous filings which would have covered different reporting periods or events.

Key Financial Figures

• $1.235 billion — gross revenue is equal to or more than $1.235 billion; (iii) the date on which we have issued
• $1 billion — date on which we have issued more than $1 billion in nonconvertible debt during the previ

Filing Documents

• d938219ddef14a.htm (DEF 14A) — 431KB
• g938219dsp002.jpg (GRAPHIC) — 165KB
• g938219dsp003.jpg (GRAPHIC) — 107KB
• g938219g13n02.jpg (GRAPHIC) — 112KB
• g938219g21h26.jpg (GRAPHIC) — 35KB
• g938219g30a88.jpg (GRAPHIC) — 21KB
• g938219g89a89.jpg (GRAPHIC) — 27KB
• 0001193125-24-115454.txt (&nbsp;) — 1069KB

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 24 Summary Compensation Table 25 Narrative Disclosure to Summary Compensation Table 25 Outstanding Equity Awards at Fiscal Year-End 35 Indemnification 36 DIRECTOR COMPENSATION 37 Cash and Equity Compensation 37 Director Compensation 38 PROPOSAL 2 RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 40 General 40 Vote Required 40 Our Recommendation 41 Pre-Approval Policies and Procedures 41 Independent Registered Public Accounting Firm Fees and Services. 41 TRANSACTIONS WITH RELATED PERSONS 42 Policies and Procedures Regarding Transactions with Related Persons 42 Certain Related Person Transactions 42

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 45 SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS 49 HOUSEHOLDING OF PROXY MATERIALS 50 OTHER MATTERS 50 i Table of Contents SANA BIOTECHNOLOGY, INC. 188 East Blaine Street, Suite 400 Seattle, Washington 98102 PROXY STATEMENT FOR THE 2024 ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON JUNE 6, 2024 This proxy statement contains information about the 2024 Annual Meeting of Stockholders (the Annual Meeting) of Sana Biotechnology, Inc., which will be held at 9:00 a.m., Pacific Time, on June 6, 2024. The Board of Directors of Sana Biotechnology, Inc. (Board) is using this proxy statement to solicit proxies for use at the Annual Meeting. Any reference to our Annual Meeting in this proxy statement also refers, as applicable, to any adjournment or postponement thereof. In this proxy statement, the terms Sana, we, us, and our refer to Sana Biotechnology, Inc. The mailing address of our principal executive offices is Sana Biotechnology, Inc., 188 East Blaine Street, Suite 400, Seattle, Washington 98102. To facilitate stockholder attendance and participation and to provide a consistent experience for all stockholders, regardless of location, the Annual Meeting will be a virtual meeting conducted via live audio webcast. You will not be able to attend the Annual Meeting physically. Instructions on how to attend and participate in the Annual Meeting are described in this proxy statement. All properly submitted proxies will be voted in accordance with the instructions contained in those proxies. If no instructions are specified, the proxies will be voted in accordance with the recommendation of our Board with respect to each of the matters to be voted on at the Annual Meeting. You may revoke your proxy before it is exercised at the Annual Meeting as described in the General Information section of this proxy statement. We made this proxy statement and our Annual Re